bioRxiv · 12 Nov 2026
mRNA/LNP-mediated expression of a ligand-independent Tie2 pathway activator, COMP-Tie2*, enables sustained endothelial stabilization
K. Radloff, C. M. Dunne, O. Keil, A. Santel, J. Kaufmann, D. Tondera
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Activation of the angiopoietin/Tie2 signaling axis is a validated strategy for endothelial stabilization. However, therapeutic Tie2 activation via angiopoietin-1 (Ang1) or Ang1-derived agonists is intrinsically limited due to several mechanism including ligand instability, competitive Ang2 inhibition, Tie2 ectodomain cleavage, VE-PTP-mediated Tie2 dephosphorylation, and ligand-induced receptor degradation. All these inhibitory mechanisms restrict both magnitude as well as duration of therapeutic Tie2 signaling, particularly under inflammatory conditions such as acute respiratory distress syndrome (ARDS) or sepsis. Here, we describe a novel ligand-independent strategy for sustained Tie2 activation based on engineered membrane-anchored Tie2 variants. By combining intracellular Tie2 kinase domains harboring naturally occurring autoactivating mutations with heterologous membrane-targeting domains, we generated truncated, constitutively active Tie2 variants that bypass extracellular ligand regulation entirely. mRNA-mediated expression of these constructs induced robust and persistent Tie2 autophosphorylation and downstream Akt-FOXO1 signaling in pulmonary endothelial cells, which exceeded COMP-Ang1-mediated activation in both strength and duration. Systemic administration of COMP-Tie2* mRNA using lung-targeted lipid nanoparticles resulted in selective pulmonary Tie2 receptor engagement in vivo. Collectively, these data establish LNP-mediated mRNA delivery of engineered recombinant receptors for intrinsic Tie2 activation as a promising novel approach for endothelial stabilization under inflammatory conditions.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.